Insider Transactions in Q2 2021 at Moderna, Inc. (MRNA)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 02
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$915,000
$183.9 P/Share
|
|
Jun 02
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Jun 01
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,062
-55.23%
|
$2,024,346
$183.46 P/Share
|
|
Jun 01
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$920,000
$184.08 P/Share
|
|
Jun 01
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
May 27
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$1,148,400
$174.2 P/Share
|
|
May 27
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$92,400
$14.85 P/Share
|
|
May 27
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.14%
|
$1,740,000
$174.2 P/Share
|
|
May 26
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.03%
|
-
|
|
May 26
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,512,000
$168.7 P/Share
|
|
May 26
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$840,000
$168.7 P/Share
|
|
May 26
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
May 26
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$840,000
$168.7 P/Share
|
|
May 26
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$125,000
$25.93 P/Share
|
|
May 25
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$1,095,600
$166.58 P/Share
|
|
May 25
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$92,400
$14.85 P/Share
|
|
May 24
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
20,000
-0.25%
|
$3,260,000
$163.89 P/Share
|
|
May 24
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+0.41%
|
$140,000
$7.6 P/Share
|
|
May 24
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$810,000
$162.45 P/Share
|
|
May 24
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
May 21
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-9.24%
|
$1,822,590
$165.32 P/Share
|
|
May 20
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$1,049,400
$159.92 P/Share
|
|
May 20
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$92,400
$14.85 P/Share
|
|
May 20
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,590,000
$159.92 P/Share
|
|
May 19
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.03%
|
-
|
|
May 19
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,395,000
$155.74 P/Share
|
|
May 19
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$775,000
$155.74 P/Share
|
|
May 19
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
May 19
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$775,000
$155.74 P/Share
|
|
May 19
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$125,000
$25.93 P/Share
|
|
May 18
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$1,056,000
$160.16 P/Share
|
|
May 18
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$92,400
$14.85 P/Share
|
|
May 17
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$795,000
$159.23 P/Share
|
|
May 17
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
May 14
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-3.59%
|
$1,723,176
$156.7 P/Share
|
|
May 13
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$1,003,200
$152.6 P/Share
|
|
May 13
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$92,400
$14.85 P/Share
|
|
May 13
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.92%
|
$2,280,000
$152.6 P/Share
|
|
May 13
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+0.46%
|
$75,000
$5.95 P/Share
|
|
May 13
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,520,000
$152.6 P/Share
|
|
May 12
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.31%
|
$770,000
$154.11 P/Share
|
|
May 12
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.31%
|
$50,000
$10.9 P/Share
|
|
May 12
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.03%
|
-
|
|
May 12
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,386,000
$154.11 P/Share
|
|
May 12
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$770,000
$154.11 P/Share
|
|
May 12
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$125,000
$25.93 P/Share
|
|
May 12
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$770,000
$154.11 P/Share
|
|
May 12
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
May 11
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$996,600
$151.31 P/Share
|
|
May 11
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+34.77%
|
$112,200
$17.89 P/Share
|